These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 25047458)

  • 1. Safety and efficacy of edoxaban, an oral factor xa inhibitor, for thromboprophylaxis after total hip arthroplasty in Japan and Taiwan.
    Fuji T; Wang CJ; Fujita S; Kawai Y; Kimura T; Tachibana S
    J Arthroplasty; 2014 Dec; 29(12):2439-46. PubMed ID: 25047458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and efficacy of edoxaban, an oral factor Xa inhibitor, versus enoxaparin for thromboprophylaxis after total knee arthroplasty: the STARS E-3 trial.
    Fuji T; Wang CJ; Fujita S; Kawai Y; Nakamura M; Kimura T; Ibusuki K; Ushida H; Abe K; Tachibana S
    Thromb Res; 2014 Dec; 134(6):1198-204. PubMed ID: 25294589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral direct factor Xa inhibition with edoxaban for thromboprophylaxis after elective total hip replacement. A randomised double-blind dose-response study.
    Raskob G; Cohen AT; Eriksson BI; Puskas D; Shi M; Bocanegra T; Weitz JI
    Thromb Haemost; 2010 Sep; 104(3):642-9. PubMed ID: 20589317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of edoxaban in patients undergoing hip fracture surgery.
    Fuji T; Fujita S; Kawai Y; Nakamura M; Kimura T; Kiuchi Y; Abe K; Tachibana S
    Thromb Res; 2014 Jun; 133(6):1016-22. PubMed ID: 24680549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Edoxaban in the prevention and treatment of thromboembolic complications from a clinical point of view.
    Barrios V; Escobar C
    Expert Rev Cardiovasc Ther; 2015; 13(7):811-24. PubMed ID: 26068539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of antithrombotic and haemorrhagic effects of edoxaban, an oral direct factor Xa inhibitor, with warfarin and enoxaparin in rats.
    Morishima Y; Honda Y; Kamisato C; Tsuji N; Kita A; Edo N; Shibano T
    Thromb Res; 2012 Sep; 130(3):514-9. PubMed ID: 22647432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral dabigatran versus enoxaparin for thromboprophylaxis after primary total hip arthroplasty (RE-NOVATE II*). A randomised, double-blind, non-inferiority trial.
    Eriksson BI; Dahl OE; Huo MH; Kurth AA; Hantel S; Hermansson K; Schnee JM; Friedman RJ;
    Thromb Haemost; 2011 Apr; 105(4):721-9. PubMed ID: 21225098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral direct factor Xa inhibitor versus enoxaparin for thromboprophylaxis after hip or knee arthroplasty: Systemic review, traditional meta-analysis, dose-response meta-analysis and network meta-analysis.
    Feng W; Wu K; Liu Z; Kong G; Deng Z; Chen S; Wu Y; Chen M; Liu S; Wang H
    Thromb Res; 2015 Dec; 136(6):1133-44. PubMed ID: 26498222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A dose-ranging study evaluating the oral factor Xa inhibitor edoxaban for the prevention of venous thromboembolism in patients undergoing total knee arthroplasty.
    Fuji T; Fujita S; Tachibana S; Kawai Y
    J Thromb Haemost; 2010 Nov; 8(11):2458-68. PubMed ID: 20723033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of venous thrombosis with an oral direct factor Xa inhibitor edoxaban by single and multiple administrations in rats.
    Morishima Y; Kamisato C; Honda Y
    Eur J Pharmacol; 2014 Nov; 742():15-21. PubMed ID: 25179572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome of Direct Oral Anticoagulant Treatment for Acute Lower Limb Deep Venous Thrombosis After Total Knee Arthroplasty Or Total Hip Arthroplasty.
    Mochizuki T; Ikari K; Yano K; Hiroshima R; Ishibashi M; Okazaki K
    Mod Rheumatol; 2019 Jul; 29(4):682-686. PubMed ID: 30041559
    [No Abstract]   [Full Text] [Related]  

  • 12. Edoxaban: a new oral direct factor xa inhibitor.
    Camm AJ; Bounameaux H
    Drugs; 2011 Aug; 71(12):1503-26. PubMed ID: 21861537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical impact of edoxaban for the patients with postoperative anemia after total hip arthroplasty.
    Izushi Y; Shiota N; Tetsunaga T; Shimada K; Egawa T; Kiuchi T; Sato T; Takuma R; Takami Y
    Eur J Orthop Surg Traumatol; 2018 Oct; 28(7):1349-1358. PubMed ID: 29730743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A dose-finding study with TAK-442, an oral factor Xa inhibitor, in patients undergoing elective total knee replacement surgery.
    Weitz JI; Cao C; Eriksson BI; Fisher W; Kupfer S; Raskob G; Spaeder J; Turpie AG
    Thromb Haemost; 2010 Dec; 104(6):1150-7. PubMed ID: 20886185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty.
    Eriksson BI; Borris LC; Friedman RJ; Haas S; Huisman MV; Kakkar AK; Bandel TJ; Beckmann H; Muehlhofer E; Misselwitz F; Geerts W;
    N Engl J Med; 2008 Jun; 358(26):2765-75. PubMed ID: 18579811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phase II study of the oral factor Xa inhibitor LY517717 for the prevention of venous thromboembolism after hip or knee replacement.
    Agnelli G; Haas S; Ginsberg JS; Krueger KA; Dmitrienko A; Brandt JT
    J Thromb Haemost; 2007 Apr; 5(4):746-53. PubMed ID: 17408408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prothrombin time-international normalized ratio is a useful marker for edoxaban efficacy in preventing venous thromboembolism after total knee arthroplasty.
    Kodato K; Ishida K; Shibanuma N; Toda A; Takayama K; Oka S; Hayashi S; Hashimoto S; Kurosaka M; Kuroda R; Matsumoto T
    Eur J Orthop Surg Traumatol; 2018 Jan; 28(1):103-108. PubMed ID: 28766070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dabigatran versus enoxaparin for prevention of venous thromboembolism after hip or knee arthroplasty: a pooled analysis of three trials.
    Friedman RJ; Dahl OE; Rosencher N; Caprini JA; Kurth AA; Francis CW; Clemens A; Hantel S; Schnee JM; Eriksson BI;
    Thromb Res; 2010 Sep; 126(3):175-82. PubMed ID: 20434759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of venous thromboembolism with an oral factor Xa inhibitor, YM150, after total hip arthroplasty. A dose finding study (ONYX-2).
    Eriksson BI; Turpie AG; Lassen MR; Prins MH; Agnelli G; Kälebo P; Wetherill G; Wilpshaar JW; Meems L;
    J Thromb Haemost; 2010 Apr; 8(4):714-21. PubMed ID: 20088935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Efficacy and Safety of Edoxaban for VTE Prophylaxis Post-Orthopedic Surgery: A Systematic Review.
    AlHajri L; Jabbari S; AlEmad H; AlMahri K; AlMahri M; AlKitbi N
    J Cardiovasc Pharmacol Ther; 2017 May; 22(3):230-238. PubMed ID: 27811198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.